Caisse de depot et placement du Quebec acquired a new stake in shares of Danaher Corporation (NYSE:DHR – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 325,142 shares of the conglomerate’s stock, valued at approximately $61,933,000.
Several other hedge funds have also recently made changes to their positions in DHR. Pointe Capital Management LLC acquired a new position in Danaher in the 2nd quarter worth approximately $403,000. Odyssean LLC purchased a new position in Danaher during the 2nd quarter worth approximately $1,146,000. Man Group plc acquired a new stake in Danaher during the 2nd quarter valued at approximately $13,980,000. First Bancorp Inc ME purchased a new stake in shares of Danaher in the 2nd quarter valued at $160,000. Finally, Polar Asset Management Partners Inc. purchased a new stake in shares of Danaher in the 2nd quarter valued at $11,391,000. 79.05% of the stock is owned by institutional investors and hedge funds.
Danaher Stock Performance
DHR opened at $215.74 on Friday. The firm has a fifty day moving average price of $198.69 and a 200 day moving average price of $192.35. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock has a market cap of $151.67 billion, a P/E ratio of 38.32, a P/E/G ratio of 2.68 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on DHR shares. Piper Sandler assumed coverage on shares of Danaher in a report on Thursday, June 11th. They set a “neutral” rating and a $200.00 target price for the company. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. Royal Bank Of Canada increased their price target on Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 22nd. HSBC reduced their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Finally, Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.
Check Out Our Latest Analysis on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
